MAPTO Survey Reveals Global Variability in Managing FVIII Inhibitors in Children on Emicizumab – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Lilianne van Stam et al, adding:
”The MAPTO Survey: Worldwide Approaches on Unmasking Factor VIII Inhibitors in Children with Emicizumab Treatment
A global survey of 102 healthcare providers across 38 countries reveals highly heterogeneous practices regarding FVIII inhibitor risk assessment and concomitant FVIII use in previously untreated hemophilia A children on emicizumab, underscoring the urgent need for evidence-based treatment guidelines.”
Title: The MAPTO survey: worldwide approaches on unmasking factor VIII inhibitors in children with emicizumab treatment: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders
Authors: Lilianne van Stam, Bridget Horstman, Pantep Angchaisuksiri, Manuel Carcao, Gili Kenet, Christoph Königs, Johnny Mahlangu, Maria Mancuso, Suely Rezende, Robert Sidonio, Alok Srivastava, Guy Young, Karin Fijnvandraat, Samantha Gouw
Read the Full Article on JTH

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 3, 2026, 18:24Alexandros Rampotas: Targeting Mutant CALR With Precision CAR-T Therapy
-
Jul 3, 2026, 18:08Ram Khandelwal: Why AI Is Transforming Patient Education and the Future of Healthcare
-
Jul 3, 2026, 17:55Miguel Bronchud: Why Congenital Neutropenia Is Often Missed
-
Jul 3, 2026, 17:35Patrick Rensen: Celebrating 25 Years in Endocrinology at Leiden University Medical Center
-
Jul 3, 2026, 16:54Alberico Catapano: The Role of Triglyceride Variability and the AIFA Reimbursement Gap
-
Jul 3, 2026, 16:44Barbara Lovrencic: Amplifying the Patient Voice at the EMA – Shaping the Future of ITP Care
-
Jul 3, 2026, 16:34Andrea Bisso: Exploring the T Cell Engagers in Autoimmune Diseases
-
Jul 3, 2026, 16:24Rizwan Ullah: Managing Severe Tirofiban-Induced Thrombocytopenia
-
Jul 3, 2026, 16:17Neeraj Jain: Maharashtra Strengthens Hemoglobinopathies and Thalassemia Care Through Integrated Public Health Collaboration